img

Global Thyrogen and Biosimilar Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Thyrogen and Biosimilar Market Insights, Forecast to 2034

THYROGEN (thyrotropin alfa for injection) contains recombinant human thyroid stimulating hormone (TSH). Thyrotropin alfa is synthesized in a genetically modified Chinese hamster ovary cell line.
Global Thyrogen and Biosimilar market is expected to reach to US$ 285 million in 2023, with a positive growth of %, compared with US$ 257 million in 2024 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Thyrogen and Biosimilar industry is evaluated to reach US$ 682.6 million in 2034. The CAGR will be 15.7% during 2023 to 2034.
Globally, Thyrogen and Biosimilar key manufacturers include Sanofi and Sato Pharmaceutical etc. Sanofi, Sato Pharmaceutical, are top 3 players and held % sales share in total in 2024.
When considering the consumption regions, % volume of Thyrogen and Biosimilar were sold to North America, Europe and Asia Pacific in 2024. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2034 and the sales share will be % in 2034. Moreover, China, plays a key role in the whole Thyrogen and Biosimilar market and estimated to attract more attentions from industry insiders and investors.
Thyrogen and Biosimilar can be divided into Brand and Biosimilar, etc. Brand is the mainstream product in the market, accounting for % sales share globally in 2024 and the proportion will be % in 2034.
Thyrogen and Biosimilar is widely used in various fields, such as Hospital, Pharmacy and Other,, etc. Hospital provides greatest supports to the Thyrogen and Biosimilar industry development. In 2024, global % sales of Thyrogen and Biosimilar went into Hospital filed and the proportion will reach to % in 2034.
Report Covers
This report presents an overview of global Thyrogen and Biosimilar market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Thyrogen and Biosimilar market with multiple angles. Items like regional sales, revenue from 2018 to 2034 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
Sato Pharmaceutical
Segment by Type
Brand
Biosimilar

Segment by Application


Hospital
Pharmacy
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2034
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Thyrogen and Biosimilar plant distribution, commercial date of Thyrogen and Biosimilar, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2034 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2034 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2034 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2034 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2034 in China. Product sales and revenue analysis of China from 2018 to 2034
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Thyrogen and Biosimilar introduction, etc. Thyrogen and Biosimilar Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Thyrogen and Biosimilar
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Thyrogen and Biosimilar Product Introduction
1.2 Market by Type
1.2.1 Global Thyrogen and Biosimilar Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Brand
1.2.3 Biosimilar
1.3 Market by Application
1.3.1 Global Thyrogen and Biosimilar Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Thyrogen and Biosimilar Sales Estimates and Forecasts 2018-2034
2.2 Global Thyrogen and Biosimilar Revenue by Region
2.2.1 Global Thyrogen and Biosimilar Revenue by Region: 2018 VS 2024 VS 2034
2.2.2 Global Thyrogen and Biosimilar Revenue by Region (2018-2023)
2.2.3 Global Thyrogen and Biosimilar Revenue by Region (2024-2034)
2.2.4 Global Thyrogen and Biosimilar Revenue Market Share by Region (2018-2034)
2.3 Global Thyrogen and Biosimilar Sales Estimates and Forecasts 2018-2034
2.4 Global Thyrogen and Biosimilar Sales by Region
2.4.1 Global Thyrogen and Biosimilar Sales by Region: 2018 VS 2024 VS 2034
2.4.2 Global Thyrogen and Biosimilar Sales by Region (2018-2023)
2.4.3 Global Thyrogen and Biosimilar Sales by Region (2024-2034)
2.4.4 Global Thyrogen and Biosimilar Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Thyrogen and Biosimilar Sales by Manufacturers
3.1.1 Global Thyrogen and Biosimilar Sales by Manufacturers (2018-2023)
3.1.2 Global Thyrogen and Biosimilar Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Thyrogen and Biosimilar in 2024
3.2 Global Thyrogen and Biosimilar Revenue by Manufacturers
3.2.1 Global Thyrogen and Biosimilar Revenue by Manufacturers (2018-2023)
3.2.2 Global Thyrogen and Biosimilar Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Thyrogen and Biosimilar Revenue in 2024
3.3 Global Key Players of Thyrogen and Biosimilar, Industry Ranking, 2021 VS 2024 VS 2023
3.4 Global Thyrogen and Biosimilar Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Thyrogen and Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Thyrogen and Biosimilar, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Thyrogen and Biosimilar, Product Offered and Application
3.8 Global Key Manufacturers of Thyrogen and Biosimilar, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Thyrogen and Biosimilar Sales by Type
4.1.1 Global Thyrogen and Biosimilar Historical Sales by Type (2018-2023)
4.1.2 Global Thyrogen and Biosimilar Forecasted Sales by Type (2024-2034)
4.1.3 Global Thyrogen and Biosimilar Sales Market Share by Type (2018-2034)
4.2 Global Thyrogen and Biosimilar Revenue by Type
4.2.1 Global Thyrogen and Biosimilar Historical Revenue by Type (2018-2023)
4.2.2 Global Thyrogen and Biosimilar Forecasted Revenue by Type (2024-2034)
4.2.3 Global Thyrogen and Biosimilar Revenue Market Share by Type (2018-2034)
4.3 Global Thyrogen and Biosimilar Price by Type
4.3.1 Global Thyrogen and Biosimilar Price by Type (2018-2023)
4.3.2 Global Thyrogen and Biosimilar Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Thyrogen and Biosimilar Sales by Application
5.1.1 Global Thyrogen and Biosimilar Historical Sales by Application (2018-2023)
5.1.2 Global Thyrogen and Biosimilar Forecasted Sales by Application (2024-2034)
5.1.3 Global Thyrogen and Biosimilar Sales Market Share by Application (2018-2034)
5.2 Global Thyrogen and Biosimilar Revenue by Application
5.2.1 Global Thyrogen and Biosimilar Historical Revenue by Application (2018-2023)
5.2.2 Global Thyrogen and Biosimilar Forecasted Revenue by Application (2024-2034)
5.2.3 Global Thyrogen and Biosimilar Revenue Market Share by Application (2018-2034)
5.3 Global Thyrogen and Biosimilar Price by Application
5.3.1 Global Thyrogen and Biosimilar Price by Application (2018-2023)
5.3.2 Global Thyrogen and Biosimilar Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Thyrogen and Biosimilar Market Size by Type
6.1.1 US & Canada Thyrogen and Biosimilar Sales by Type (2018-2034)
6.1.2 US & Canada Thyrogen and Biosimilar Revenue by Type (2018-2034)
6.2 US & Canada Thyrogen and Biosimilar Market Size by Application
6.2.1 US & Canada Thyrogen and Biosimilar Sales by Application (2018-2034)
6.2.2 US & Canada Thyrogen and Biosimilar Revenue by Application (2018-2034)
6.3 US & Canada Thyrogen and Biosimilar Market Size by Country
6.3.1 US & Canada Thyrogen and Biosimilar Revenue by Country: 2018 VS 2024 VS 2034
6.3.2 US & Canada Thyrogen and Biosimilar Sales by Country (2018-2034)
6.3.3 US & Canada Thyrogen and Biosimilar Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Thyrogen and Biosimilar Market Size by Type
7.1.1 Europe Thyrogen and Biosimilar Sales by Type (2018-2034)
7.1.2 Europe Thyrogen and Biosimilar Revenue by Type (2018-2034)
7.2 Europe Thyrogen and Biosimilar Market Size by Application
7.2.1 Europe Thyrogen and Biosimilar Sales by Application (2018-2034)
7.2.2 Europe Thyrogen and Biosimilar Revenue by Application (2018-2034)
7.3 Europe Thyrogen and Biosimilar Market Size by Country
7.3.1 Europe Thyrogen and Biosimilar Revenue by Country: 2018 VS 2024 VS 2034
7.3.2 Europe Thyrogen and Biosimilar Sales by Country (2018-2034)
7.3.3 Europe Thyrogen and Biosimilar Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Thyrogen and Biosimilar Market Size
8.1.1 China Thyrogen and Biosimilar Sales (2018-2034)
8.1.2 China Thyrogen and Biosimilar Revenue (2018-2034)
8.2 China Thyrogen and Biosimilar Market Size by Application
8.2.1 China Thyrogen and Biosimilar Sales by Application (2018-2034)
8.2.2 China Thyrogen and Biosimilar Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Thyrogen and Biosimilar Market Size by Type
9.1.1 Asia Thyrogen and Biosimilar Sales by Type (2018-2034)
9.1.2 Asia Thyrogen and Biosimilar Revenue by Type (2018-2034)
9.2 Asia Thyrogen and Biosimilar Market Size by Application
9.2.1 Asia Thyrogen and Biosimilar Sales by Application (2018-2034)
9.2.2 Asia Thyrogen and Biosimilar Revenue by Application (2018-2034)
9.3 Asia Thyrogen and Biosimilar Sales by Region
9.3.1 Asia Thyrogen and Biosimilar Revenue by Region: 2018 VS 2024 VS 2034
9.3.2 Asia Thyrogen and Biosimilar Revenue by Region (2018-2034)
9.3.3 Asia Thyrogen and Biosimilar Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Thyrogen and Biosimilar Market Size by Type
10.1.1 Middle East, Africa and Latin America Thyrogen and Biosimilar Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Thyrogen and Biosimilar Market Size by Application
10.2.1 Middle East, Africa and Latin America Thyrogen and Biosimilar Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Thyrogen and Biosimilar Sales by Country
10.3.1 Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue by Country: 2018 VS 2024 VS 2034
10.3.2 Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Thyrogen and Biosimilar Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Thyrogen and Biosimilar Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Sanofi Thyrogen and Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 Sato Pharmaceutical
11.2.1 Sato Pharmaceutical Company Information
11.2.2 Sato Pharmaceutical Overview
11.2.3 Sato Pharmaceutical Thyrogen and Biosimilar Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Sato Pharmaceutical Thyrogen and Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sato Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Thyrogen and Biosimilar Industry Chain Analysis
12.2 Thyrogen and Biosimilar Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Thyrogen and Biosimilar Production Mode & Process
12.4 Thyrogen and Biosimilar Sales and Marketing
12.4.1 Thyrogen and Biosimilar Sales Channels
12.4.2 Thyrogen and Biosimilar Distributors
12.5 Thyrogen and Biosimilar Customers
13 Market Dynamics
13.1 Thyrogen and Biosimilar Industry Trends
13.2 Thyrogen and Biosimilar Market Drivers
13.3 Thyrogen and Biosimilar Market Challenges
13.4 Thyrogen and Biosimilar Market Restraints
14 Key Findings in The Global Thyrogen and Biosimilar Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Thyrogen and Biosimilar Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Brand
Table 3. Major Manufacturers of Biosimilar
Table 4. Global Thyrogen and Biosimilar Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Thyrogen and Biosimilar Revenue Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Thyrogen and Biosimilar Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Thyrogen and Biosimilar Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Thyrogen and Biosimilar Revenue Market Share by Region (2018-2023)
Table 9. Global Thyrogen and Biosimilar Revenue Market Share by Region (2024-2034)
Table 10. Global Thyrogen and Biosimilar Sales Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 11. Global Thyrogen and Biosimilar Sales by Region (2018-2023) & (K Units)
Table 12. Global Thyrogen and Biosimilar Sales by Region (2024-2034) & (K Units)
Table 13. Global Thyrogen and Biosimilar Sales Market Share by Region (2018-2023)
Table 14. Global Thyrogen and Biosimilar Sales Market Share by Region (2024-2034)
Table 15. Global Thyrogen and Biosimilar Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Thyrogen and Biosimilar Sales Share by Manufacturers (2018-2023)
Table 17. Global Thyrogen and Biosimilar Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Thyrogen and Biosimilar Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Thyrogen and Biosimilar, Industry Ranking, 2021 VS 2024 VS 2023
Table 20. Thyrogen and Biosimilar Price by Manufacturers 2018-2023 (US$/Unit)
Table 21. Global Thyrogen and Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Thyrogen and Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thyrogen and Biosimilar as of 2024)
Table 23. Global Key Manufacturers of Thyrogen and Biosimilar, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Thyrogen and Biosimilar, Product Offered and Application
Table 25. Global Key Manufacturers of Thyrogen and Biosimilar, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Thyrogen and Biosimilar Sales by Type (2018-2023) & (K Units)
Table 28. Global Thyrogen and Biosimilar Sales by Type (2024-2034) & (K Units)
Table 29. Global Thyrogen and Biosimilar Sales Share by Type (2018-2023)
Table 30. Global Thyrogen and Biosimilar Sales Share by Type (2024-2034)
Table 31. Global Thyrogen and Biosimilar Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Thyrogen and Biosimilar Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Thyrogen and Biosimilar Revenue Share by Type (2018-2023)
Table 34. Global Thyrogen and Biosimilar Revenue Share by Type (2024-2034)
Table 35. Thyrogen and Biosimilar Price by Type (2018-2023) & (US$/Unit)
Table 36. Global Thyrogen and Biosimilar Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Thyrogen and Biosimilar Sales by Application (2018-2023) & (K Units)
Table 38. Global Thyrogen and Biosimilar Sales by Application (2024-2034) & (K Units)
Table 39. Global Thyrogen and Biosimilar Sales Share by Application (2018-2023)
Table 40. Global Thyrogen and Biosimilar Sales Share by Application (2024-2034)
Table 41. Global Thyrogen and Biosimilar Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Thyrogen and Biosimilar Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Thyrogen and Biosimilar Revenue Share by Application (2018-2023)
Table 44. Global Thyrogen and Biosimilar Revenue Share by Application (2024-2034)
Table 45. Thyrogen and Biosimilar Price by Application (2018-2023) & (US$/Unit)
Table 46. Global Thyrogen and Biosimilar Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada Thyrogen and Biosimilar Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Thyrogen and Biosimilar Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada Thyrogen and Biosimilar Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Thyrogen and Biosimilar Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Thyrogen and Biosimilar Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Thyrogen and Biosimilar Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada Thyrogen and Biosimilar Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Thyrogen and Biosimilar Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Thyrogen and Biosimilar Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 56. US & Canada Thyrogen and Biosimilar Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Thyrogen and Biosimilar Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Thyrogen and Biosimilar Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Thyrogen and Biosimilar Sales by Country (2024-2034) & (K Units)
Table 60. Europe Thyrogen and Biosimilar Sales by Type (2018-2023) & (K Units)
Table 61. Europe Thyrogen and Biosimilar Sales by Type (2024-2034) & (K Units)
Table 62. Europe Thyrogen and Biosimilar Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Thyrogen and Biosimilar Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Thyrogen and Biosimilar Sales by Application (2018-2023) & (K Units)
Table 65. Europe Thyrogen and Biosimilar Sales by Application (2024-2034) & (K Units)
Table 66. Europe Thyrogen and Biosimilar Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Thyrogen and Biosimilar Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Thyrogen and Biosimilar Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 69. Europe Thyrogen and Biosimilar Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Thyrogen and Biosimilar Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Thyrogen and Biosimilar Sales by Country (2018-2023) & (K Units)
Table 72. Europe Thyrogen and Biosimilar Sales by Country (2024-2034) & (K Units)
Table 73. China Thyrogen and Biosimilar Sales by Type (2018-2023) & (K Units)
Table 74. China Thyrogen and Biosimilar Sales by Type (2024-2034) & (K Units)
Table 75. China Thyrogen and Biosimilar Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Thyrogen and Biosimilar Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Thyrogen and Biosimilar Sales by Application (2018-2023) & (K Units)
Table 78. China Thyrogen and Biosimilar Sales by Application (2024-2034) & (K Units)
Table 79. China Thyrogen and Biosimilar Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Thyrogen and Biosimilar Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Thyrogen and Biosimilar Sales by Type (2018-2023) & (K Units)
Table 82. Asia Thyrogen and Biosimilar Sales by Type (2024-2034) & (K Units)
Table 83. Asia Thyrogen and Biosimilar Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Thyrogen and Biosimilar Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Thyrogen and Biosimilar Sales by Application (2018-2023) & (K Units)
Table 86. Asia Thyrogen and Biosimilar Sales by Application (2024-2034) & (K Units)
Table 87. Asia Thyrogen and Biosimilar Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Thyrogen and Biosimilar Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Thyrogen and Biosimilar Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 90. Asia Thyrogen and Biosimilar Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Thyrogen and Biosimilar Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Thyrogen and Biosimilar Sales by Region (2018-2023) & (K Units)
Table 93. Asia Thyrogen and Biosimilar Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America Thyrogen and Biosimilar Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Thyrogen and Biosimilar Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Thyrogen and Biosimilar Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Thyrogen and Biosimilar Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Thyrogen and Biosimilar Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Thyrogen and Biosimilar Sales by Country (2024-2034) & (K Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Thyrogen and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Sanofi Thyrogen and Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. Sato Pharmaceutical Company Information
Table 113. Sato Pharmaceutical Description and Major Businesses
Table 114. Sato Pharmaceutical Thyrogen and Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Sato Pharmaceutical Thyrogen and Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sato Pharmaceutical Recent Developments
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Thyrogen and Biosimilar Distributors List
Table 120. Thyrogen and Biosimilar Customers List
Table 121. Thyrogen and Biosimilar Market Trends
Table 122. Thyrogen and Biosimilar Market Drivers
Table 123. Thyrogen and Biosimilar Market Challenges
Table 124. Thyrogen and Biosimilar Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Thyrogen and Biosimilar Product Picture
Figure 2. Global Thyrogen and Biosimilar Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Thyrogen and Biosimilar Market Share by Type in 2024 & 2034
Figure 4. Brand Product Picture
Figure 5. Biosimilar Product Picture
Figure 6. Global Thyrogen and Biosimilar Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Thyrogen and Biosimilar Market Share by Application in 2024 & 2034
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Other
Figure 11. Thyrogen and Biosimilar Report Years Considered
Figure 12. Global Thyrogen and Biosimilar Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Thyrogen and Biosimilar Revenue 2018-2034 (US$ Million)
Figure 14. Global Thyrogen and Biosimilar Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 15. Global Thyrogen and Biosimilar Revenue Market Share by Region (2018-2034)
Figure 16. Global Thyrogen and Biosimilar Sales 2018-2034 ((K Units)
Figure 17. Global Thyrogen and Biosimilar Sales Market Share by Region (2018-2034)
Figure 18. US & Canada Thyrogen and Biosimilar Sales YoY (2018-2034) & (K Units)
Figure 19. US & Canada Thyrogen and Biosimilar Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Thyrogen and Biosimilar Sales YoY (2018-2034) & (K Units)
Figure 21. Europe Thyrogen and Biosimilar Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Thyrogen and Biosimilar Sales YoY (2018-2034) & (K Units)
Figure 23. China Thyrogen and Biosimilar Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Asia (excluding China) Thyrogen and Biosimilar Sales YoY (2018-2034) & (K Units)
Figure 25. Asia (excluding China) Thyrogen and Biosimilar Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Thyrogen and Biosimilar Sales YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Thyrogen and Biosimilar Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
Figure 29. The Top 5 and 10 Largest Manufacturers of Thyrogen and Biosimilar in the World: Market Share by Thyrogen and Biosimilar Revenue in 2024
Figure 30. Global Thyrogen and Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 31. Global Thyrogen and Biosimilar Sales Market Share by Type (2018-2034)
Figure 32. Global Thyrogen and Biosimilar Revenue Market Share by Type (2018-2034)
Figure 33. Global Thyrogen and Biosimilar Sales Market Share by Application (2018-2034)
Figure 34. Global Thyrogen and Biosimilar Revenue Market Share by Application (2018-2034)
Figure 35. US & Canada Thyrogen and Biosimilar Sales Market Share by Type (2018-2034)
Figure 36. US & Canada Thyrogen and Biosimilar Revenue Market Share by Type (2018-2034)
Figure 37. US & Canada Thyrogen and Biosimilar Sales Market Share by Application (2018-2034)
Figure 38. US & Canada Thyrogen and Biosimilar Revenue Market Share by Application (2018-2034)
Figure 39. US & Canada Thyrogen and Biosimilar Revenue Share by Country (2018-2034)
Figure 40. US & Canada Thyrogen and Biosimilar Sales Share by Country (2018-2034)
Figure 41. U.S. Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 42. Canada Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 43. Europe Thyrogen and Biosimilar Sales Market Share by Type (2018-2034)
Figure 44. Europe Thyrogen and Biosimilar Revenue Market Share by Type (2018-2034)
Figure 45. Europe Thyrogen and Biosimilar Sales Market Share by Application (2018-2034)
Figure 46. Europe Thyrogen and Biosimilar Revenue Market Share by Application (2018-2034)
Figure 47. Europe Thyrogen and Biosimilar Revenue Share by Country (2018-2034)
Figure 48. Europe Thyrogen and Biosimilar Sales Share by Country (2018-2034)
Figure 49. Germany Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 50. France Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 51. U.K. Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 52. Italy Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 53. Russia Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 54. China Thyrogen and Biosimilar Sales Market Share by Type (2018-2034)
Figure 55. China Thyrogen and Biosimilar Revenue Market Share by Type (2018-2034)
Figure 56. China Thyrogen and Biosimilar Sales Market Share by Application (2018-2034)
Figure 57. China Thyrogen and Biosimilar Revenue Market Share by Application (2018-2034)
Figure 58. Asia Thyrogen and Biosimilar Sales Market Share by Type (2018-2034)
Figure 59. Asia Thyrogen and Biosimilar Revenue Market Share by Type (2018-2034)
Figure 60. Asia Thyrogen and Biosimilar Sales Market Share by Application (2018-2034)
Figure 61. Asia Thyrogen and Biosimilar Revenue Market Share by Application (2018-2034)
Figure 62. Asia Thyrogen and Biosimilar Revenue Share by Region (2018-2034)
Figure 63. Asia Thyrogen and Biosimilar Sales Share by Region (2018-2034)
Figure 64. Japan Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 65. South Korea Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 66. China Taiwan Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 67. Southeast Asia Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 68. India Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Thyrogen and Biosimilar Sales Market Share by Type (2018-2034)
Figure 70. Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue Market Share by Type (2018-2034)
Figure 71. Middle East, Africa and Latin America Thyrogen and Biosimilar Sales Market Share by Application (2018-2034)
Figure 72. Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue Market Share by Application (2018-2034)
Figure 73. Middle East, Africa and Latin America Thyrogen and Biosimilar Revenue Share by Country (2018-2034)
Figure 74. Middle East, Africa and Latin America Thyrogen and Biosimilar Sales Share by Country (2018-2034)
Figure 75. Brazil Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 76. Mexico Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 77. Turkey Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 78. Israel Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 79. GCC Countries Thyrogen and Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 80. Thyrogen and Biosimilar Value Chain
Figure 81. Thyrogen and Biosimilar Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries